Cocrystal Pharma Inc

-0.02 (-2.53%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)89.33M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.28 Million
Adjusted EPS-$0.04
See more estimates
10-Day MA$0.95
50-Day MA$1.05
200-Day MA$1.32
See more pivots

Cocrystal Pharma Inc Stock, NASDAQ:COCP

19805 North Creek Parkway, Bothell, Washington 98011
United States of America
Phone: +1.786.459.1831
Number of Employees:


Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded in 2008 and is headquartered in Bothell, WA.